Therapeutic Botulinum Toxin | Market Insights | Global | 2023
Despite the negative impact of the COVID-19 pandemic, the global market for therapeutic BTX will exhibit rapid growth through 2031. The need to return for maintenance procedures will sustain demand among existing patients, while rising demand driven by expanding indications will fuel procedure volume growth over the forecast period.
This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for therapeutic BTX in the US, Europe, and Asia Pacific region from 2019 through 2031.